Quantcast

Latest Brussels Stories

2014-09-15 16:28:40

Romosozumab Currently in Phase 3 Clinical Development, Pivotal Data Expected in 2016 THOUSAND OAKS, Calif. and BRUSSELS, Sept. 15, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and UCB (Euronext Brussels:UCB) today announced results from several exploratory analyses of the Phase 2 study evaluating romosozumab in postmenopausal women with low bone mineral density (BMD). Romosozumab is an investigational bone-forming agent that is designed to work by inhibiting the protein sclerostin, thereby...

2014-09-10 08:36:43

BRUSSELS, September 10, 2014 /PRNewswire/ -- BICS, a global wholesale carrier for voice, mobile data and capacity services, has provided its complete product range of voice and roaming services for Unitel's newly launched MNO in Sao Tome and Principe, improving international connectivity for residents and visitors to the island in the Gulf of Guinea. Within only two months, BICS had deployed full connectivity for international voice services, SMS messaging, signalling...

2014-09-01 00:21:00

- VIMPAT® (lacosamide) C-V approved in the U.S. as monotherapy in the treatment of partial-onset seizures in adults with epilepsy(1) BRUSSELS, Sept. 1, 2014 /PRNewswire/ -- 0700 (CEST) - regulated information -- UCB announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for VIMPAT(®) (lacosamide) C-V as monotherapy in the treatment of partial-onset seizures in patients with epilepsy aged 17 years and older.(1) This is a new...

2014-08-21 04:22:08

BRUSSELS, August 21, 2014 /PRNewswire/ -- Operators see rapid increase in voice, SMS and data roaming as football supporters, players and officials share experience with friends and relatives BICS, a global provider of international connectivity and interoperability services, has reported operators in Brazil saw a spike of 400% in the use of roaming services in Brazil during June and July as match spectators, media and footballers from around the world...

2014-07-23 08:31:01

- Brivaracetam is the newest investigational medicine to emerge from UCB's rich late-stage pipeline BRUSSELS, July 23, 2014 /PRNewswire/ -- regulated information -- UCB today announced an important advance in its research and development pipeline with positive topline results from the latest Phase 3 study with brivaracetam. This study was designed to evaluate the efficacy and safety of brivaracetam (100 and 200 mg/day, without titration) compared to placebo, as adjunctive treatment in adult...

2014-07-02 12:27:19

NEWTOWN, Pa., July 2, 2014 /PRNewswire/ -- At the recent European Pharmaceutical Market Research Association (EphMRA) conference in Brussels, Asif Javed (OSG) and Joe Schneider (BD, a fortune 500 Global Medical Device and Diagnostic company) presented a paper on how to move from a product centric to customer centric strategy. The paper discussed a real life case study on how to create success by putting the needs and wants of a business' most valuable customers first, a process driven...

2014-06-23 23:12:15

Drugmakers for the first time must now report adverse drug reactions (ADRs) caused by their products in all uses, including off-label use. In a July 1, 2014 webinar, FDAnews and EU law expert Elisabethann Wright, a partner in Hogan Lovells’ Brussels, Belgium office, will provide answers and in-depth information. Falls Church, VA (PRWEB) June 23, 2014 Complying With the New EMA Pharmacovigilance Rules Filling the Obligations Without Committing Off-Label Violations **FDAnews Webinar**...

2014-06-12 08:34:17

BRUSSELS, June 12, 2014 /PRNewswire/ -- Europioneers will reward the people behind the companies! The European Commission, Deloitte, European Young Innovators Forum and HUB Institute, have launched the second edition of the Europioneers Awards, a competition to reward the best European Web Entrepreneurs and their successful initiatives, as part of the EC StartUp Europe activities framework for web entrepreneurship. This Award is a unique opportunity to...

2014-06-12 08:25:25

INDICE+ S.A.'s "Holy Grail" of the golf game uses vibrational signals through the user's mobile device for precise tee off, potentially making the need for bunkers obsolete BRUSSELS, June 12, 2014 /PRNewswire/ -- INDICE+ S.A. announces the immediate availability of Mobile Golf Tempo v1.5, its golfing app for Android and now also for iOS. Photo - http://photos.prnewswire.com/prnh/20140611/117094 The updated app is an effective and easy way for the tempo of the pros to take root in...

2014-06-03 04:22:03

BRUSSELS, June 3, 2014 /PRNewswire/ -- BICS industry survey reveals majority of mobile executives are preparing for RCS launch, but RoI and interoperability remain key challenges BICS, a global provider of wholesale carrier services, today announced the results of a survey of senior executives at mobile operators, revealing the key challenges in delivering Rich Communications Services (RCS) to provide a fast response to the ever-growing number of...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related